Graves Kurt

Vertex Pharmaceuticals Inc.

EVP, Chief Commercial Officer

Avg. Two Year Performance

54% Avg. Purchase Return 24% Compound

(35%) Avg. Sale Return (16%) Compound

Holdings: 60.48K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions